photodynamic therapy

photodynamic therapy(Technology)

Tumor photodynamic therapy uses photosensitizers and lasers to destroy cancer cells with high efficiency. It is a non-invasive therapy.

1. Definition

Photodynamic therapy for tumors uses photosensitizers and lasers to efficiently destroy cancer cells and is a non-invasive therapy. It was approved for clinical use by the US FDA in 1996 and approved for clinical use by China's SFDA in 2003. The photosensitizer is injected intravenously, and the cancer tissue absorbs a large amount of the photosensitizer, while the normal tissue absorbs very little; the cancer is irradiated with a special laser, and under the action of light energy, the photosensitizer acts on the cancer cells. The cancer cells become toxic and necrotic, and the tumors gradually disappear.

photodynamic therapy, cancer treatment, cancer

2. Tumor treatment forms

Surgery → Chemotherapy → Radiotherapy → Immune function therapy → Photodynamic therapy has become the fifth internationally recognized cancer treatment method

3. Treatment process

Step 1: Inject photosensitizer into the patient.

Step 2: Patients usually have to wait 40 to 50 hours after the injection

The third step: irradiate the lesion area with laser to kill the cancer cells

4. Advantages

Minimally invasive - no surgery, no wounds, little pain

​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​​

Prevent cancer recurrence - eliminate tiny lesions and reduce tumor recurrence

Few complications - low toxicity, especially suitable for advanced or elderly and frail cancer patients

5. Clinical application

• Oropharyngeal cancer: The effective rate for early stage oral cancer and nasopharyngeal cancer is over 75%
• Esophageal cancer: effectively improves the obstruction of progressive esophageal cancer; very effective in the treatment of cervical esophageal cancer; can treat submucosal disseminated esophageal cancer; for esophageal cancer that grows into the cavity and has been stent-ed, it can eliminate intraluminal tumors
• Barrett’s esophagus: Not only can it effectively eliminate Barrett’s esophageal epithelium, but it can also treat early-stage esophageal adenocarcinoma.
• Lung cancer: For early-stage bronchial cancer, the curative effect is quite significant, and for progressive obstructive bronchial cancer, the improvement rate reaches 85%
• Gastric cancer: For early gastric cancer, the rate is 85%; effectively improve the symptoms of progressive gastric cancer
• Bladder cancer: carcinoma in situ, 71% effective against progressive cancer
• Other cancers that are effective in treating: colorectal cancer, cholangiocarcinoma, especially hilar cholangiocarcinoma, pancreatic cancer and ampullary cancer, abdominal tumors, thoracoperitoneal mesothelioma, liver cancer, brain tumors, genitourinary tract cancer

Still have questions?

Reach our care team for personalized guidance on diagnosis, treatment, and insurance.

Request a Consultation